<DOC>
	<DOCNO>NCT01294371</DOCNO>
	<brief_summary>The purpose study ass rate administration add-back therapy patient endometriosis Russian Federation , 6-month course gonadoliberin agonist leuprorelin 3.75 mg .</brief_summary>
	<brief_title>Observational Program Assess Routine Use Add-back Therapy Patients With Endometriosis Russian Federation , Planned 6-month Course Lucrin DepotÂ® ( Leuprorelin )</brief_title>
	<detailed_description>This non-interventional , observational program Lucrin Depot ( leuprorelin acetate ) add-back therapy ( hormone non-hormone ) prescribe usual manner accordance term local marketing authorization regard dose , population indication ( leuprorelin acetate ) regard local guideline therapeutic recommendation ( add-back therapy ) . The rationale study necessity characterize patient population long-term leuprorelin acetate administration Russian Federation . Further , important characterize compliance , tolerability , safety profile therapy routine clinical care set Russian Federation .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<criteria>Age 18 50 year Written Patient Consent Use/Disclosure Data Diagnosis genital endometriosis confirm laparoscopy ( external genital endometriosis ) ultrasound ( internal genital endometriosis ) Candidate treatment Lucrin Depot 6month course Patients suspected endometriosis suffer chronic pelvic pain reason pain excluded Contraindications administration Lucrin Depot ( leuprorelin ) : Hypersensitivity leuprorelin similar product protein origin excipients drug product composition Vaginal bleeding unknown etiology Hysterectomy Pregnancy lactation Menopause ( absence cyclic menstrual hemorrhage 1 year start program ) Acute infectious period , inclusive acute inflammatory diseases small pelvic organs Other contraindication make patient participation impossible ( investigator judgment ) Previous enrollment present program Extragenital endometriosis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Lucrin Depot</keyword>
	<keyword>genital endometriosis</keyword>
	<keyword>6 month therapy</keyword>
</DOC>